Research news

Date: 
03/04/2019

Researcher in Focus - Amy Buckley

This month’s Researcher in Focus is Amy Buckley. Amy completed her BSc in Pharmacology at University College Dublin in 2015.

Date: 
03/04/2019

Daffodil Day - thanks for your support!

From baking to brewing, bike-riding to daffodil-accessorising, once again the Irish research community were huge supporters when it came to raising vital funds for the Irish Cancer Society on Daffodil Day.

Date: 
03/04/2019

The UCD Patient Voice in Cancer Research Workshop - Wednesday 10 April 2019

Calling all patients, survivors and carers: Have your say in conducting a survivorship experience study.

Date: 
01/04/2019

BReast cAncer surVivors and Employment (BRAVE): Facilitators and barriers in returning to or staying at work in Ireland

Naomi Algeo, an Irish Research Council funded PhD Candidate under the Discipline of Occupational Therapy at Trinity College Dublin, is currently undertaking a research study exploring challenges that breast cancer survivors face when returning to or staying at work post-cancer diagnosis. To do th

Date: 
01/04/2019

Psycho-Social Consequences of Cancer: The Irish Psycho-Social Oncology Network (IPSON)

Last week saw 2019's first Members Meeting of the Irish Pyscho-Social Oncology Network (IPSON) take place in Dublin. IPSON works closely with the Irish Cancer Society, and aims to advance services for cancer patients in Ireland. So, what is Psycho-Social oncology, and what does IPSON do?

movember
Date: 
26/03/2019

Largest prostate cancer research programme in Ireland calls for patients to be key to cancer care

Movember Ireland and Irish Cancer Society funded prostate cancer research programme – IPCOR – calls for patients to input into nationwide cancer registry

Irish Cancer Society researcher Naoise Synnott
Date: 
21/03/2019

Irish women to be first in the world to trial potential new breast cancer treatment

Irish Cancer Society calls on public to give to Daffodil Day volunteers in communities and workplaces today to help ensure more patients can benefit from vital cancer research